Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotie Therapies OYJ

+ Add to Watchlist

BTH1V:FH

0.1870 EUR 0.0080 4.10%

As of 11:29:58 ET on 01/30/2015.

Company Profile for Biotie Therapies OYJ (BTH1V)

Biotie Therapies Oyj is a biopharmaceutical company. The Company develops drugs that treat dependence disorders, inflammatory diseases, and thrombosis.

Contact Information

Biotie Therapies OYJ

Tykistokatu 6
Turku, 20520
Finland
Phone: 358-2-274-8900
Fax: 358-2-274-8910

Key Executives for Biotie Therapies OYJ (BTH1V)

Timo VeromaaPresident/CEODavid CookCFO/Chief Business Ofcr
Stephen I BandakChief Medical OfficerIan J MasseyPresident:US Operations/COO
Kristian RantalaVP:Finance & Administration

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil